{"id":11488,"date":"2025-07-26T16:27:29","date_gmt":"2025-07-26T14:27:29","guid":{"rendered":"https:\/\/valintermed.com\/?p=11488"},"modified":"2025-07-26T16:27:29","modified_gmt":"2025-07-26T14:27:29","slug":"gepatoblastoma","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/hepatoblastoma\/","title":{"rendered":"Hepatoblastoma"},"content":{"rendered":"
<\/div>\n

Hepatoblastoma is a rare malignant tumor process that occurs in the liver, mainly in children under three years of age. It is a primary liver tumor consisting of immature hepatocytes and mesenchymal cells and is characterized by an aggressive course and a high potential for metastasis. Hepatoblastoma accounts for 1-2% of all cases of childhood tumors and is more common in boys than in girls, with a ratio of 2:1. Clinically, the disease can manifest as an enlarged liver, pain in the right hypochondrium, vomiting and weight loss. Rapid diagnosis and proper treatment remain key aspects for improving patient survival.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n